NYSE:GMED
Globus Medical (GMED)
Financials 
Technical Analysis 
Jun 11, 2026, 12:00 amThis summary was created by AI, based on 1 opinions in the last 12 months.
Globus Medical (GMED-N) is operating in a challenging environment for medical device companies. The general sentiment towards the sector has taken a downturn, with increased scrutiny and skepticism from the market, particularly impacting larger players like Medtronic. Investors are cautious as they navigate the complexities of regulatory pressures and economic factors affecting healthcare spending. This backdrop raises concerns about the profitability and growth prospects for companies like Globus Medical, making some experts wary about its future performance in the medical device landscape. Despite these challenges, there could be opportunities for niche players, but caution is warranted due to prevailing market trends.
He recommended it around 18 months ago, and it has doubled in price. Drawbacks before: had no international presence and not enough salespeople, but that has turned around, as reflected in the price jump. Earnings growing 10-15% annually. No debt, but pay no dividend. Buy half a position and watch, but don't buy heavily because it may
drop badly during a correction.
Since he recommended this, it’s gone from $22 to $46. This is medical technology for spying related injuries. The stock price has taken off because the company has gotten their act together and has started to move outside of the US. Their sales teams are in place. A lot of their competitors have not been allocating capital towards the spine business. This company just came out with a new robotic invention that will help surgeons do all the spine surgeries. Earnings have jumped up nicely, and he is expecting anywhere from $143-$178 a share over the next couple of years, but we are still seeing the stock trading at roughly 32X earnings. Wait for a pullback or just buy half for the moment.
David DriscollThis is a tiny little $2 billion company that is in robotics of spinal care. Growing at a wonderful rate, but the street hasn’t adapted to them.
David Driscoll- «
- ‹
- 1
- ›
- »
Globus Medical (GMED) Frequently Asked Questions
What is Globus Medical stock symbol?
Globus Medical is a American stock, trading under the symbol GMED (previously GMED-N on Stockchase) on the New York Stock Exchange (GMED). It is usually referred to as NYSE:GMED or GMED
Is Globus Medical a buy or a sell?
In the last year, 1 stock analyst published opinions about GMED (previously GMED-N on Stockchase). 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for Globus Medical.
Is Globus Medical a good investment or a top pick?
Globus Medical was recommended as a Top Pick by David Driscoll on 2016-06-07. Read the latest stock experts ratings for Globus Medical.
Why is Globus Medical stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
Is Globus Medical worth watching?
1 stock analyst on Stockchase covered Globus Medical in the last year. It is a trending stock that is worth watching.
What is Globus Medical stock price?
On 2026-06-10, Globus Medical (GMED) stock closed at a price of $80.86.
The market hates medical devices now and there's little money made in bigger players like Medtronic.